March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Microbubble Delivery of DiI to the Ocular Posterior Segment: Comparison of Intravitreal and Suprachoroidal Injection Routes
Author Affiliations & Notes
  • Gabriela S. Seiler
    Molecular Biomedical Sciences,
    North Carolina State University, Raleigh, North Carolina
  • Sydney E. Cartiff
    Clinical Sciences,
    North Carolina State University, Raleigh, North Carolina
  • Paul A. Dayton
    Biomedical Engineering, North Carolina State University and The University of North Carolina, Chapel Hill, North Carolina
  • Jacklyn H. Salmon
    Clinical Sciences,
    North Carolina State University, Raleigh, North Carolina
  • Brian C. Gilger
    Clinical Sciences,
    North Carolina State University, Raleigh, North Carolina
  • Footnotes
    Commercial Relationships  Gabriela S. Seiler, None; Sydney E. Cartiff, None; Paul A. Dayton, None; Jacklyn H. Salmon, None; Brian C. Gilger, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4639. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gabriela S. Seiler, Sydney E. Cartiff, Paul A. Dayton, Jacklyn H. Salmon, Brian C. Gilger; Microbubble Delivery of DiI to the Ocular Posterior Segment: Comparison of Intravitreal and Suprachoroidal Injection Routes. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4639.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the distribution of dye to the ocular posterior segment via an intravitreal (IV) or anterior suprachoroidal space (SCS) injection of free or microbubble-contained 1,1’-Dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine iodide (DiI).

Methods: : Fresh canine cadaver eyes received either an IV or SCS injection (250 uL) of free or microbubble-incorporated DiI. Eyes injected with microbubbles were simultaneously imaged with ultrasound and either received 0, 1, or 3 pulses to destroy the microbubbles and release the incorporated Dil once they reached the ocular posterior segment. All eyes were frozen within 1 minute of injection using 2-methylbutane in liquid nitrogen, stored at -80°C until sectioned at 5-10 um at -30°C, and mounted on superfrost slides. Amount of dye in the retina as observed on a fluorescent microscope was semi-quantified using a score of 0 (none) to 4 (retina saturated with DiI) in representative areas of the superior, central, and inferior retina by two masked observers. Mean cumulative scores (of the 3 anatomic areas) were analyzed using Wilcoxon rank sum test and differences considered significant at P<0.05.

Results: : Ultrasound imaging illustrated that microbubble contrast was present in the ocular posterior segment within 10 seconds of injection. Mean cumulative scores of retinal dye were similar between IV (2.0 +/- 1.7) and SCS (1.8 +/- 0.88) for free DiI, and slightly higher for 1 pulse microbubble delivery of DiI (IV: 2.9 +/- 1.4 ; SCS: 2.8 +/- 2.3). However, 3 pulse microbubble destruction resulted in significantly higher delivery of DiI to SCS (P=0.043) (4.1 +/- 0.8) compared to IV (2.7 +/- 1.1).

Conclusions: : These results support the theory that microbubbles as a delivery vehicle and site-targeted ultrasound may improve drug delivery to the ocular posterior segment. Furthermore, these results suggest that the SCS may allow enhanced targeted drug delivery to the ocular posterior segment and use of these modalities together (i.e., microbubbles and SCS injections) may result in more effective drug delivery to the retina.

Keywords: injection • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×